Search

everythinglearnresearchcommunity

for

Search:↓

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The document explains different hair and scalp conditions and their treatments.

Topical 1% sildenafil is not recommended for treating alopecia areata in children.

In a Tuscan pediatric clinic, 7.19% of children had hair or scalp disorders, with nonscarring alopecia being the most common.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Infliximab may cause hair loss in Crohn's disease patients.

The model accurately detects alopecia areata with 84.3% accuracy.

A 31-year-old man's hair turned white suddenly, likely due to alopecia areata.

Both ASR I and ASR II are effective scalp reduction techniques, with ASR I creating finer scars and ASR II removing more bald area and reducing stretch-back.

Scalp reduction can effectively treat male pattern baldness, especially when combined with hair transplants.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

A comprehensive scoring system for alopecia areata severity is needed.

FUE and SMP together can effectively treat hair loss, needing fewer procedures.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

JAK inhibitors offer new hope for treating severe alopecia areata.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Calcipotriol does not improve the effectiveness of squaric acid dibutylester in treating alopecia areata.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.